Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
Titel:
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
Auteur:
Wells, Athol U Flaherty, Kevin R Brown, Kevin K Inoue, Yoshikazu Devaraj, Anand Richeldi, Luca Moua, Teng Crestani, Bruno Wuyts, Wim A Stowasser, Susanne Quaresma, Manuel Goeldner, Rainer-Georg Schlenker-Herceg, Rozsa Kolb, Martin